NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹77 Cr | ₹34 Cr | ₹32 Cr | ₹30 Cr | ₹16 Cr |
What is the latest Total Debt ratio of NGL FINECHEM ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹77 Cr |
| Mar2024 | ₹34 Cr |
| Mar2023 | ₹32 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹16 Cr |
How is Total Debt of NGL FINECHEM Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹77 Cr | 126.73 | |
| Mar2024 | ₹34 Cr | 4.63 | |
| Mar2023 | ₹32 Cr | 8.32 | |
| Mar2022 | ₹30 Cr | 82.41 | |
| Mar2021 | ₹16 Cr | - | |
Compare Total Debt of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,898.1 Cr | -3% | 13.4% | 197.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -3% |
13.4% |
197.3% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses